This page is for patients comparing ICL surgery costs in London who want to understand what the price includes, what drives the variation between providers, and why Blue Fin Vision® does not promote patient financing.
What Drives the Cost of ICL Surgery
ICL surgery is more expensive than LASIK for three reasons: the implant itself is significantly more costly than the disposables used in laser surgery; the surgical complexity is higher, requiring intraocular precision and a full post-operative monitoring programme; and the aftercare commitment, annual vault reviews for life, is built into the cost at Blue Fin Vision® rather than charged separately.⁴ The lifetime vault monitoring commitment is often not included in headline ICL fees at other providers, patients discover the ongoing cost only after surgery.
The EVO+ Visian ICL is a proprietary device manufactured by STAAR Surgical¹, it is not interchangeable with generic alternatives. Power calculation accuracy determines the refractive result; technique determines the vault; monitoring determines the long-term safety. These are not elements where cost-cutting improves outcomes.
What the Blue Fin Vision® ICL Fee Includes
- Pre-operative assessment: full biometry, OCT, topography, endothelial count.
- Peripheral iridotomy (if required): included.
- ICL implant (EVO+ Visian ICL): included, premium platform only.²
- Surgeon fee: Mr Hove performs every procedure personally.
- Partner hospital facility fee: Chase Lodge, Phoenix Chelmsford, One Hatfield.
- Post-operative reviews: Day 1, Week 1, Month 1, Month 6 included.
- Annual vault monitoring: first year included; ongoing programme.
On Patient Financing
Blue Fin Vision® does not promote monthly payment schemes or encourage patients to finance elective eye surgery. ICL is a significant investment, the decision to proceed should be made because the patient is ready, clinically and financially, not because a payment plan made it feel affordable today.³ Patients who need time to plan are supported to return when ready. The recommendation is not influenced by whether the patient can pay this week.
Who This Is Not For
This page is not for patients seeking the lowest-cost ICL option in London. Budget ICL providers exist, and some offer the procedure at significantly lower fees. What those fees typically exclude is the depth of pre-operative assessment, the monitoring programme, and the named consultant continuity that determine long-term outcomes. Cost is a legitimate consideration. It is not the only consideration.
Clinical Perspective
The price of ICL surgery at Blue Fin Vision® reflects the implant cost, the surgical complexity, the post-operative commitment, and the named consultant performing every procedure. It does not reflect marketing overheads or commercial volume targets. Vault monitoring that catches a drift before it causes cataract is worth more than the monitoring appointment costs. That is the long-term economics of doing ICL properly.
Clinical Takeaway
ICL costs more than LASIK because the implant, surgical complexity, and lifetime monitoring programme are more substantial. At Blue Fin Vision®, Mr Mfazo Hove performs every ICL procedure personally, not delegated to an associate or registrar. The fee is fully inclusive, pre-operative assessment, surgery, PI if required, post-operative reviews, and first-year vault monitoring. Patient financing is not promoted. The decision to proceed should be made without financial pressure, and patients who need time to plan are supported to return when ready without any commercial pressure to book immediately.
References
- Alfonso JF, Baamonde B, Madrid-Costa D, Fernandes P, Jorge J, Montes-Mico R. Collagen copolymer toric posterior chamber phakic intraocular lenses to correct high myopic astigmatism. J Cataract Refract Surg. 2010;36(8):1349–1357.
- Pesando PM, Ghiringhello MP, Di Meglio G, Fanton G. Posterior chamber phakic intraocular lens (ICL) for hyperopia: ten-year follow-up. J Cataract Refract Surg. 2007;33(9):1579–1584.
- Jaycock PD, O’Brart DPS, Rosen ES, Marshall J. Five-year follow-up of LASIK for hyperopia. Ophthalmology. 2005;112(2):191–199.
- Packer M. Meta-analysis and review: effectiveness, safety, and central port design of the intraocular collamer lens. Clin Ophthalmol. 2016;10:1059–1077.
